Please Wait.....
Report
Mexico Clinical Trials Market Report and Forecast 2025-2034
Market Report I 2025-06-20 I 250 Pages I EMR Inc.
The Mexico clinical trials market was valued at USD 364.56 Million in 2024, driven by rising biotechnology investments and strengthened regulatory support with enhanced infrastructure initiatives in the region. The market is anticipated to grow at a CAGR of 4.10% during the forecast period of 2025-2034, with the values likely to reach USD 544.85 Million by 2034. The market growth is driven by rising clinical trials in Mexico as they are relatively more affordable than in the United States or Europe, offering a cost advantage without compromising quality.
Mexico Clinical Trials Market Overview
Clinical trials are controlled research studies conducted to evaluate the safety, efficacy, and optimal use before regulatory approval and widespread clinical application. According to Regulatory Focus factsheet, Mexico registered around 5,000 clinical studies by April 2024. The clinical trials market in Mexico is growing steadily, driven by a skilled workforce, cost efficiency, diverse patient population, and supportive regulatory environment, making it an attractive location for global pharmaceutical research.
Mexico Clinical Trials Market Growth Drivers
Adoption of Digital Platforms to Promote Ease in Regulatory Approvals
A key growth driver in the Mexico clinical trials market is the recent digital transformation of regulatory processes. In February 2023, the Federal Commission for Protection against Health Risks (Cofepris) launched the Digital Platform for Research and Clinical Trials (Digipris), which enables researchers to submit and manage clinical trial protocols entirely online. By eliminating the need for in-person appointments and physical paperwork, Digipris significantly accelerates approval timelines, enhances transparency, and improves regulatory efficiency, making Mexico a more attractive destination for both domestic and international clinical research sponsors.
Mexico Clinical Trials Market Trends
Some of the notable trends include the ease in regulations to promote clinical trial activities.
Regulatory Streamlining is Expected to Boost the Market Growth
Mexico continues to strengthen its position as a hub for clinical research through regulatory enhancements. In March 2025, the Ministry of Health and Cofepris introduced new reliance criteria allowing approvals from agencies such as the EMA, FDA, MHRA, and Health Canada to expedite clinical trial authorizations. Effective by June 2025, this reform is expected to accelerate trial approvals, attract global sponsors, and significantly boost market growth.
Mexico Clinical Trials Market Segmentation
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Phase
- Phase I
- Phase II
- Phase III
- Phase IV
Market Breakup by Service Type
- Laboratory Services
- Bioanalytical Testing Services
??- Cell-Based Assay
??- Virology Testing
??- Serology, Immunogenicity, & Neutralizing Antibodies
??- PK/PD Testing
??- Method Development, Optimization & Validation
??- Biomarker Testing
??- Other Bioanalytical Testing Services
- Decentralized Clinical Trial Services
- Patient Recruitment
- Site Identification
- Analytical Testing Services
- Clinical Trial Supply & Logistic Services
- Protocol Designing
- Clinical Trial Data Management Services
- Medical Device Testing Services
- Other Service
Market Breakup by Therapeutic Areas
- Oncology
- Infectious Diseases
- Neurology
- Metabolic Disorders
- Immunology
- Cardiology
- Genetic Diseases
- Women's Health
- Other Therapeutic Areas
Market Breakup by Type of Pharmaceutical Product
- Small Molecules
- Monoclonal Antibodies
- Vaccine
- Cell & Gene Therapy
- Other Applications
Market Breakup by Study Design
- Interventional
- Observational
Market Breakup by Delivery Model
- Full-Service Outsourcing (FSO) Model
- Functional Service Provider (FSP) Model
- Hybrid Model
Market Breakup by End User
- Pharmaceutical & Biopharmaceutical Companies
- Medical Devices Companies
- Academic Institutes
- Other
Mexico Clinical Trials Market Share
Laboratory Services Projected to Hold Significant Share for Segmentation by Service Type
By service type, the market is categorized into laboratory services, bioanalytical testing services, decentralized clinical trial services, patient recruitment, site identification, analytical testing services, clinical trial supply and logistic services, protocol designing, clinical trial data management services, medical device testing services, and other services. Laboratory services are expected to dominate, owing to their essential function in clinical diagnostics and continuous demand for precise and standardized testing procedures. For instance, in November 2024, UL Solutions Inc., a global leader in applied safety science, expanded its laboratory capacity and capabilities in Mexico to support the rising demand for product safety and performance testing. This move highlights the increasing focus on laboratory and analytical services within Mexico's clinical trials market, reflecting growing investment in local infrastructure to meet the needs of pharmaceutical and medical device manufacturers across Latin America.
Oncology to Lead the Market Share by Therapeutic Area
According to therapeutic area, the market is segmented into oncology, infectious diseases, neurology, metabolic disorders, immunology, cardiology, genetic diseases, women's health, and others. According to the Global Cancer Observatory (2022), Mexico is expected to have over 500,000 five-year prevalent cancer cases, highlighting a significant disease burden. Hence, oncology is projected to lead due to increasing cancer prevalence, rising awareness, and significant investment in research and development of targeted therapies and immuno-oncology treatments.
Leading Players in the Mexico Clinical Trials Market
The key features of the market report comprise funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
IQVIA Holdings Inc.
IQVIA is a global leader in advanced analytics and clinical research. In Mexico, the company plays a significant role in the clinical trials market by offering innovative solutions such as Clinical Data Analytics Solutions (CDAS), orchestrated clinical trials, and tech-enabled services. These platforms use artificial intelligence and machine learning to streamline trial oversight, accelerate data processing, and enhance decision-making. IQVIA's presence supports Mexico's growing reputation as a strategic hub for efficient, technology-driven clinical research and pharmaceutical development.
Althian Solutions Pvt. Ltd.
Althian is a leading provider of specialized clinical research services. The company plays a vital role in the market by offering comprehensive solutions such as clinical trial supplies management, biomarker and laboratory services, medical writing, and risk management. Known for its regulatory compliance and operational efficiency, Althian supports global firms in conducting successful trials across diverse therapeutic areas.
Parexel International Corporation
Parexel is a global leader in providing comprehensive clinical trial and regulatory services. The company offers solutions across a wide range of therapeutic areas, including oncology, infectious diseases, as well as cell and gene therapies. In Mexico, Parexel plays a crucial role in advancing clinical trials by leveraging its global expertise and local regulatory knowledge to optimize drug development, streamline trials, and ensure efficient market entry. The company's services are essential for multinational pharmaceutical and biotech companies conducting research in the region.
PPD (Thermo Fisher Scientific)
PPD is a part of Thermo Fisher Scientific, established in 1985 and headquartered in Wilmington, North Carolina. PPD, its clinical research branch plays a significant role in the clinical trials market. Known for digital transformation in clinical development, Thermo Fisher is recognized for its decentralized trials capabilities, diverse patient engagement, and advanced pharmacovigilance solutions. With a focus on improving patient access and trial efficiency, it helps accelerate the development of new medicines, fostering innovation and addressing key challenges like patient diversity and socioeconomic barriers in clinical trials.
Other key players in the market include Cohortias, Fractals Clinical Research, MCR (Marketing & Clinical Research), Medpace Holdings Inc., SGS de Mexico, and Syneos Health, among others.
Key Questions Answered in the Mexico Clinical Trials Market Report
- What was the Mexico clinical trials market value in 2024?
- What is the Mexico clinical trials market forecast outlook for 2025-2034?
- What are the major factors aiding the Mexico clinical trials market demand?
- How has the market performed so far, and how is it anticipated to perform in the coming years?
- What are the market's major drivers, opportunities, and restraints?
- What is the major Mexico clinical trials market trends?
- Which phase is expected to dominate the market segment?
- Which service type is projected to lead the market segment?
- Which therapeutic area is anticipated to drive the market segment?
- Which application is likely to dominate the market segment?
- Who are the key players involved in the Mexico clinical trials market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Clinical Trials Market Overview
3.1 Latin America Clinical Trials Market
3.1.1 Latin America Clinical Trials Market Historical Value (2018-2024)
3.1.2 Latin America Clinical Trials Market Forecast Value (2025-2034)
3.2 Mexico Clinical Trials Market
3.2.1 Mexico Clinical Trials Market Historical Value (2018-2024)
3.2.2 Mexico Clinical Trials Market Forecast Value (2025-2034)
4 Mexico Clinical Trials Market Landscape
4.1 Mexico Clinical Trials Market: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Mexico Clinical Trials Market: Service Landscape
4.2.1 Analysis By Phase
4.2.2 Analysis By Service Type
4.2.3 Analysis By Therapeutic Areas
4.2.4 Analysis By Type of Pharmaceutical Product
5 Mexico Clinical Trials Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 PESTEL Analysis
5.3.1 Political
5.3.2 Economic
5.3.3 Social
5.3.4 Technological
5.3.5 Legal
5.3.6 Environment
5.4 Porter's Five Forces Model
5.4.1 Bargaining Power of Suppliers
5.4.2 Bargaining Power of Buyers
5.4.3 Threat of New Entrants
5.4.4 Threat of Substitutes
5.4.5 Degree of Rivalry
5.5 Key Demand Indicators
5.6 Key Price Indicators
5.7 Industry Events, Initiatives, and Trends
5.8 Value Chain Analysis
6 Mexico Clinical Trials Market Segmentation (218-2034)
6.1 Mexico Clinical Trials Market (2018-2034) by Phase
6.1.1 Market Overview
6.1.2 Phase I
6.1.3 Phase II
6.1.4 Phase III
6.1.5 Phase IV
6.2 Mexico Clinical Trials Market (2018-2034) by Service Type
6.2.1 Market Overview
6.2.2 Laboratory Services
6.2.3 Bioanalytical Testing Services
6.2.3.1 Cell-Based Assay
6.2.3.2 Virology Testing
6.2.3.3 Serology, Immunogenicity, & Neutralizing Antibodies
6.2.3.4 PK/PD Testing
6.2.3.5 Method Development, Optimization & Validation
6.2.3.6 Biomarker Testing
6.2.3.7 Other Bioanalytical Testing Services
6.2.4 Decentralized Clinical Trial Services
6.2.5 Patient Recruitment
6.2.6 Site Identification
6.2.7 Analytical Testing Services
6.2.8 Clinical Trial Supply & Logistic Services
6.2.9 Protocol Designing
6.2.10 Clinical Trial Data Management Services
6.2.11 Medical Device Testing Services
6.2.12 Other Service
6.3 Mexico Clinical Trials Market (2018-2034) by Therapeutic Areas
6.3.1 Market Overview
6.3.2 Oncology
6.3.3 Infectious Diseases
6.3.4 Neurology
6.3.5 Metabolic Disorders
6.3.6 Immunology
6.3.7 Cardiology
6.3.8 Genetic Diseases
6.3.9 Women's Health
6.3.10 Others
6.4 Mexico Clinical Trials Market (2018-2034) by Type of Pharmaceutical Product
6.4.1 Market Overview
6.4.2 Small Molecules
6.4.3 Monoclonal Antibodies
6.4.4 Vaccine
6.4.5 Cell & Gene Therapy
6.4.6 Other Applications
6.5 Mexico Clinical Trials Market (2018-2034) by Study Design
6.5.1 Market Overview
6.5.2 Interventional
6.5.3 Observational
6.6 Mexico Clinical Trials Market (2018-2034) by Delivery Model
6.6.1 Market Overview
6.6.2 Full-Service Outsourcing (FSO) Model
6.6.3 Functional Service Provider (FSP) Model
6.6.4 Hybrid Model
6.7 Mexico Clinical Trials Market (2018-2034) by End User
6.7.1 Market Overview
6.7.2 Pharmaceutical & Biopharmaceutical Companies
6.7.3 Medical Devices Companies
6.7.4 Academic Institutes
6.7.5 Other
7 Regulatory Framework
8 Funding and Investment Analysis
8.1 Analysis by Funding Instances
8.2 Analysis by Type of Funding
8.3 Analysis by Funding Amount
8.4 Analysis by Leading Players
8.5 Analysis by Leading Investors
8.6 Analysis by Geography
9 Strategic Initiatives
9.1 Analysis by Partnership Instances
9.2 Analysis by Type of Initiatives
9.3 Analysis by Leading Players
9.4 Analysis by Geography
10 Supplier Landscape
10.1 Market Share Analysis, By Country (Top 5 Companies)
10.2 IQVIA Holdings Inc.
10.2.1 Financial Analysis
10.2.2 Product Portfolio
10.2.3 Demographic Reach and Achievements
10.2.4 Company News and Developments
10.2.5 Certifications
10.3 Althian Solutions Pvt. Ltd.
10.3.1 Financial Analysis
10.3.2 Product Portfolio
10.3.3 Demographic Reach and Achievements
10.3.4 Company News and Developments
10.3.5 Certifications
10.4 Cohortias
10.4.1 Financial Analysis
10.4.2 Product Portfolio
10.4.3 Demographic Reach and Achievements
10.4.4 Company News and Developments
10.4.5 Certifications
10.5 Fractals Clinical Research
10.5.1 Financial Analysis
10.5.2 Product Portfolio
10.5.3 Demographic Reach and Achievements
10.5.4 Company News and Developments
10.5.5 Certifications
10.6 MCR (Marketing & Clinical Research)
10.6.1 Financial Analysis
10.6.2 Product Portfolio
10.6.3 Demographic Reach and Achievements
10.6.4 Company News and Developments
10.6.5 Certifications
10.7 Parexel International Corporation
10.7.1 Financial Analysis
10.7.2 Product Portfolio
10.7.3 Demographic Reach and Achievements
10.7.4 Company News and Developments
10.7.5 Certifications
10.8 Medpace Holdings Inc.
10.8.1 Financial Analysis
10.8.2 Product Portfolio
10.8.3 Demographic Reach and Achievements
10.8.4 Company News and Developments
10.8.5 Certifications
10.9 SGS de Mexico
10.9.1 Financial Analysis
10.9.2 Product Portfolio
10.9.3 Demographic Reach and Achievements
10.9.4 Company News and Developments
10.9.5 Certifications
10.10 Syneos Health
10.10.1 Financial Analysis
10.10.2 Product Portfolio
10.10.3 Demographic Reach and Achievements
10.10.4 Company News and Developments
10.10.5 Certifications
11 Mexico Clinical Trials Market - Distribution Model (Additional Insight)
11.1 Overview
11.2 Potential Distributors
11.3 Key Parameters for Distribution Partner Assessment
12 Key Opinion Leaders (KOL) Insights (Additional Insight)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security